Home > Insider Trading > Filing (0001237899-20-000014)

Filing Details

Accession Number:: 0001237899-20-000014
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-03-10 16:05:39
Reporting Period:: 2020-03-09

Accepted Time:: 2020-03-10 16:05:39
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
872589	Regeneron Pharmaceuticals Inc.	REGN	Pharmaceutical Preparations (2834)	133444607

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1225474	L Joseph Goldstein	777 Old Saw Mill River Road Tarrytown NY 10591		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2020-03-09	2,000	$33.42	11,643	No	4	M	Direct
Common Stock	Disposition	2020-03-09	200	$468.14	11,443	No	4	S	Direct
Common Stock	Disposition	2020-03-09	100	$469.80	11,343	No	4	S	Direct
Common Stock	Disposition	2020-03-09	200	$470.83	11,143	No	4	S	Direct
Common Stock	Disposition	2020-03-09	100	$471.34	11,043	No	4	S	Direct
Common Stock	Disposition	2020-03-09	73	$474.88	10,970	No	4	S	Direct
Common Stock	Disposition	2020-03-09	327	$475.31	10,643	No	4	S	Direct
Common Stock	Disposition	2020-03-09	200	$476.16	10,443	No	4	S	Direct
Common Stock	Disposition	2020-03-09	500	$479.21	9,943	No	4	S	Direct
Common Stock	Disposition	2020-03-09	300	$482.82	9,643	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Non-Qualified Stock Option (right to buy)	Disposition	2020-03-09	2,000	$0.00	2,000	$33.42

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2021-01-03	No	4	M	Direct

Footnotes

Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
Represents volume-weighted average price of sales of 327 shares of Company stock on March 9, 2020 at prices ranging from $475.19 to $475.68. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 9, 2020 at each separate price.
Represents volume-weighted average price of sales of 200 shares of Company stock on March 9, 2020 at prices ranging from $476.15 to $476.17. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 9, 2020 at each separate price.
Represents volume-weighted average price of sales of 500 shares of Company stock on March 9, 2020 at prices ranging from $479.05 to $479.34. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 9, 2020 at each separate price.
Represents volume-weighted average price of sales of 300 shares of Company stock on March 9, 2020 at prices ranging from $482.51 to $482.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 9, 2020 at each separate price.
The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant.